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Tital:Cost-Effectiyeness Analysis of Osteoporosis Scre,ening in Kerman
Ai--si:';lc1
Introduction: Osteoporosis is the most corxmon metabolic bone disease" characterized in
particuiar rvith leduced amount of bone minerals ancl matrix. The high prer,aience of the
disease and associated fractures is among the fhctors that incur 
-qreat treatmenl costs and
cause mortality in corring decades. hrvestigation into the ffinancial] burclen of osteoporrisis
irr{ranshcrvedthatthecostperciisability-adjustedlifeyear(DAI-Y)isr-i.\/i1[rials].
N'Iethodology; il,is cross-seciional. econometric, cost-cl ctivencss stucly was conductecl in
t 
' 
t i. The eligible subjects included all people over cc i,ears of age in Kerman County. The
statistical population included all r'vomen and ruL'll okler than ir years in Kerman. llirir. First.
screening was conducted in tu,'o sta-qes. The first stage inciuded the administration of the
osteoporosis self-assessment tool and completion of the questionnaire. The seconrl staqe was
the administration of dual x-ray absorptiometry ql)XA t fol the subjects at high risk. fhe
Markov decision-tree urodel was made in TreeAge Y , \ ) . Llsiylo data obtained from this and
other studies. Frnally^ the cost-effectiveness analr,sis rvas con<luctecl. In addition. the
sensitii.,ity analysis of uncertaili), ptratneters of the model u,as can-it-ti out.
Findings: In total. q'Yr out of \,"' persons! invited tbr tace-to-tace intervieu, al horne. did
the intenier.r, (ir.Y%). ciY peopie 1c1.1%) were women and rYolo l,ere illiterate a1d ir0zo
were resident in the city. A total of 1rY people rvlto took the 
-quiclance for densitornetry
lr'erforme(i 'i tr subjects with Densitl.(^.Y,o , Y\'.i-\/./\\1-Y\'.\'y CI). In the analysis t,f iogistic
rcgression, the variables of llcation. 
-eencler and knou,n risi, o1'osteopor"osis u,ere
significantl.v correlated rvith DXA acceptance. auci osteopolrsis also increased witlr ;r.gc.
'fhe cosls of botl-r OST anct DXA nrethods are preseutecl in terms of health insnrance. fhe
third strates)' cost. tvhich is i ',\'il\ i.Y: ftials. costs more than olhel strategies. 1'he
effectiVeness of each strateglr is \.''A, a.rr. i..r1. respectively, uhrch rs tite tltrr-t.l tnost
desirable strategy. The third strategy is to peiform Osl- using DXA at the highest cost ancl it:
ialueis \1i.v\ir.1i.
Cotrclusion: 'I'his study shorved that less than one thilil of people orel the agLr of el . wcre





As a result. the cost-effectiveness of osteoporosis screening with OST/DXA is greater tlian
with DXA alone or do nothin-s. Therefore, healthcare insurance policymakers are
recommended to cover the costs of osteoporosis screening.
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